Short-term beneficial effects of methylene blue on kidney damage in septic shock patients.
until further notice
SourceIntensive Care Medicine, 34, 2, (2008), pp. 350-4
Article / Letter to editor
Display more detailsDisplay less details
IMM - Institute for Molecules and Materials
Intensive Care Medicine
SubjectIGMD 2: Molecular gastro-enterology and hepatology; IGMD 7: Iron metabolism; IGMD 9: Renal disorder; N4i 1: Pathogenesis and modulation of inflammation; NCMLS 2: Metabolism, transport and motion; NCMLS 5: Membrane transport and intracellular motility; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; Synthetic Organic Chemistry; UMCN 1.2: Molecular diagnosis, prognosis and monitoring; UMCN 4.1: Microbial pathogenesis and host defense; UMCN 5.4: Renal disorders
OBJECTIVE: We previously demonstrated that upregulation of renal inducible nitric oxide synthase (iNOS) is associated with proximal tubule injury during systemic inflammation in humans. In this study we investigated the short-term effect of methylene blue (MB), an inhibitor of the NO pathway, on kidney damage and function in septic shock patients. DESIGN AND SETTING: A prospective clinical study conducted in an intensive care unit. PATIENTS: Nine patients (four men, five women, mean age 71 +/- 3 years) with confirmed or suspected bacterial infection and with refractory septic shock defined as a mean arterial pressure < or = 70 mmHg despite norepinephrine infusion > or = 0.2 microg/kg per minute. INTERVENTIONS: A 4 h continuous intravenous infusion of 1 mg/kg MB per hour. MEASUREMENTS AND RESULTS: The urinary excretion of NO metabolites decreased with median 90% (range 75-95%) from baseline to 6 h after MB administration. The first 24 h creatinine clearance improved by 51% (18-173%) after MB treatment but was still strongly impaired. During the first 6 h after the start of MB treatment both the urinary excretion of cytosolic glutathione S-transferase A1-1 and P1-1, markers for proximal and distal tubule damage, respectively, decreased by 45% (10-70%) and 70% (40-85) vs. baseline. After termination of the MB infusion the NO metabolites and markers of tubular injury returned to pretreatment levels. CONCLUSIONS: In septic patients with refractory shock short-term infusion of MB is associated with a decrease in NO production and an attenuation of the urinary excretion of renal tubular injury markers.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.